The Role of Vimentin 3 in Ameloblastomas: A Novel Tumor Biomarker
This study identifies VIM3 expression in ABLs, distinct from VIMFL, suggesting its potential as a biomarker. Additionally, mitochondrial dysfunction may play a role in ABL tumorigenesis.
Authors
- Emre BARIŞ (ORCID: https://orcid.org/0000-0001-5096-4279)
- Melanie von Brandenstein (ORCID: https://orcid.org/0000-0002-1499-7644)
- Sibel Elif Gültekin (ORCID: https://orcid.org/0000-0002-0732-3617)
- İpek Atak Seçen (ORCID: https://orcid.org/0000-0001-9663-5454)
- Heike Goebel (ORCID: https://orcid.org/0000-0002-0171-7025)
- Leyla Arslan Bozdağ (ORCID: https://orcid.org/0000-0002-4133-0319)
Institutions
- University of Cologne (DE)
- University Hospital Cologne (DE)
- Gazi University (TR)
Publication Details
- Journal
- Oral Diseases
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1111/odi.15396
- Primary Topic
- Oral and Maxillofacial Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutscher Akademischer Austauschdienst
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu